Article
Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization.
PloS one - 1 Jan 2014
Darsalia Vladimer, Hua Sansan, Larsson Martin, Mallard Carina, Nathanson David, Nyström Thomas, Sjöholm Åke, Johansson Maria E, Patrone Cesare
Abstract excerpt
Exendin-4 is a glucagon-like receptor 1 agonist clinically used against type 2 diabetes that has also shown neuroprotective effects in experimental stroke models. However, while the neuroprotective efficacy of Exendin-4 has been thoroughly investigated if the pharmacological treatment starts befo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
